124 related articles for article (PubMed ID: 38155077)
1. Prognostic factors in resolution of nonalcoholic fatty liver disease post bariatric surgery in adolescents.
Bacha F; Gupta R; Jenkins TM; Brandt ML; Inge TH; Kleiner DE; Xanthakos SA;
Surg Obes Relat Dis; 2024 Apr; 20(4):367-375. PubMed ID: 38155077
[TBL] [Abstract][Full Text] [Related]
2. The impact of bariatric surgery on liver enzymes in people with obesity: A 5-year observational study.
Elhelw O; Ragavan S; Majeed W; Alkhaffaf B; Mohammed N; Senapati S; Ammori BJ; Robinson JA; Syed AA
Surgeon; 2024 Feb; 22(1):e26-e33. PubMed ID: 37567846
[TBL] [Abstract][Full Text] [Related]
3. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
[TBL] [Abstract][Full Text] [Related]
4. Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients.
Uehara D; Seki Y; Kakizaki S; Horiguchi N; Tojima H; Yamazaki Y; Sato K; Yamada M; Uraoka T; Kasama K
Obes Surg; 2019 Apr; 29(4):1195-1201. PubMed ID: 30542827
[TBL] [Abstract][Full Text] [Related]
5. Bariatric surgery in severely obese adolescents improves major comorbidities including hyperuricemia.
Oberbach A; Neuhaus J; Inge T; Kirsch K; Schlichting N; Blüher S; Kullnick Y; Kugler J; Baumann S; Till H
Metabolism; 2014 Feb; 63(2):242-9. PubMed ID: 24332707
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Comparison of the Effect of Gastric Bypass to Sleeve Gastrectomy on Liver Function in a Bariatric Cohort: Tehran Obesity Treatment Study (TOTS).
Motamedi MAK; Khalaj A; Mahdavi M; Valizadeh M; Hosseinpanah F; Barzin M
Obes Surg; 2019 Feb; 29(2):511-518. PubMed ID: 30298459
[TBL] [Abstract][Full Text] [Related]
7. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
[TBL] [Abstract][Full Text] [Related]
8. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
[TBL] [Abstract][Full Text] [Related]
9. Effects of Bariatric Surgery on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease.
Ooi GJ; Burton PR; Doyle L; Wentworth JM; Bhathal PS; Sikaris K; Cowley MA; Roberts SK; Kemp W; Earnest A; O'Brien PE; Brown WA
Obes Surg; 2017 Jun; 27(6):1533-1542. PubMed ID: 27966066
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of bariatric surgery on resolution of nonalcoholic steatohepatitis (NASH): An external validation and application of a clinical NASH score.
Tan CH; Al-Kalifah N; Ser KH; Lee YC; Chen JC; Lee WJ
Surg Obes Relat Dis; 2018 Oct; 14(10):1600-1606. PubMed ID: 30077664
[TBL] [Abstract][Full Text] [Related]
11. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.
Sell H; Divoux A; Poitou C; Basdevant A; Bouillot JL; Bedossa P; Tordjman J; Eckel J; Clément K
J Clin Endocrinol Metab; 2010 Jun; 95(6):2892-6. PubMed ID: 20375212
[TBL] [Abstract][Full Text] [Related]
12. Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients.
Billeter AT; Senft J; Gotthardt D; Knefeli P; Nickel F; Schulte T; Fischer L; Nawroth PP; Büchler MW; Müller-Stich BP
Obes Surg; 2016 Aug; 26(8):1867-74. PubMed ID: 26660688
[TBL] [Abstract][Full Text] [Related]
13. Impact of bariatric surgery on non-alcoholic fatty liver disease.
Major P; Pędziwiatr M; Rubinkiewicz M; Stanek M; Głuszewska A; Pisarska M; Małczak P; Budzyński A; Budzyński P
Pol Przegl Chir; 2017 Apr; 89(2):1-4. PubMed ID: 28537562
[TBL] [Abstract][Full Text] [Related]
14. Type 2 Diabetes Mellitus and Simple Glucose Metabolism Parameters may Reliably Predict Nonalcoholic Fatty Liver Disease Features.
Cazzo E; Jimenez LS; Gestic MA; Utrini MP; Chaim FHM; Chaim FDM; Pareja JC; Chaim EA
Obes Surg; 2018 Jan; 28(1):187-194. PubMed ID: 28741239
[TBL] [Abstract][Full Text] [Related]
15. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.
Cherla DV; Rodriguez NA; Vangoitsenhoven R; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
Surg Endosc; 2020 May; 34(5):2266-2272. PubMed ID: 31359195
[TBL] [Abstract][Full Text] [Related]
16. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
[TBL] [Abstract][Full Text] [Related]
18. Impact of weight-loss surgery and diabetes status on serum ALT levels.
Xourafas D; Ardestani A; Ashley SW; Tavakkoli A
Obes Surg; 2012 Oct; 22(10):1540-7. PubMed ID: 22610995
[TBL] [Abstract][Full Text] [Related]
19. Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score.
Yeo SC; Ong WM; Cheng KSA; Tan CH
Obes Surg; 2019 Apr; 29(4):1295-1300. PubMed ID: 30635812
[TBL] [Abstract][Full Text] [Related]
20. Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement.
Nobili V; Vajro P; Dezsofi A; Fischler B; Hadzic N; Jahnel J; Lamireau T; McKiernan P; McLin V; Socha P; Tizzard S; Baumann U
J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):550-61. PubMed ID: 25591123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
